Managing Distress in Malignant Brain Cancer - Ph II Randomized Crontrolled Trial
Conditions: Brain Tumor; Brain Metastases; Brain Cancer; Metastatic Lung Cancer; Metastatic Breast Cancer; Metastatic Melanoma; Metastatic Colon Cancer; Metastatic Kidney Cancer Interventions: Behavioral: CALM; Behavioral: Treatment as usual Sponsors: Virginia Commonwealth University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Short Term Outcomes After PRoton And photoN radiOtherapy for IDH Mutated Grade 2 and 3 Gliomas
Conditions: Glioma; Radiotherapy; Complications Sponsors: Erasmus Medical Center; Medical Center Haaglanden; Leiden University Medical Center; HollandPTC; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Institute Verbeeten; Universitaire Ziekenhuizen KU Leuven; Maastro Clinic, The Netherlands; University Medical Center Groningen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Validation Study of a Serum-miRNA Signature in Glioma Patients.
Conditions: Biomarker Interventions: Diagnostic Test: Validation of miRNA-serum signatures associated with IDH1 status Sponsors: Regina Elena Cancer Institute; Azienda Ospedaliero Universitaria di Sassari; Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; University of Roma La Sapienza; Plymouth State University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
Conditions: Autoimmune Encephalitis; Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma
Conditions: Glioma, Malignant Interventions: Diagnostic Test: FET PET Sponsors: Singapore General Hospital; National Cancer Centre, Singapore; National Neuroscience Institute Singapore; Duke-NUS Centre of Quantitative Medicine; Duke-NUS Khoo Pilot Award (Collaborative) 2021 Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma
Conditions: Glioma, Malignant; New Diagnosis Tumor Interventions: Biological: NSC-CRAd-S-pk7; Dietary Supplement: N-acetylcysteine amide (NACA) Sponsors: Northwestern University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors
Conditions: Postoperative Delirium Interventions: Drug: Dexmedetomidine Sponsors: Beijing Tiantan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Guided Meditation During Radiation Therapy for Brain Tumors
Conditions: Brain Neoplasms Interventions: Behavioral: 5-Minute, Audio-Recorded Guided Mediation Practice Sponsors: University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Conditions: Glioma; Medulloblastoma; Ependymoma Interventions: Drug: PLX038 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Recurrent High Grade Glioma Treated by LITT
Conditions: Recurrent High Grade Glioma Interventions: Device: LITT; Other: Control Sponsors: Beijing Tiantan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Study of Olutasidenib and Temozolomide in HGG
Conditions: High Grade Glioma; Astrocytoma; Astrocytoma, Grade III; Astrocytoma, Grade IV; Diffuse Intrinsic Pontine Glioma; WHO Grade III Glioma; WHO Grade IV Glioma; Metastatic Brain Tumor; Diffuse Midline Glioma, H3 K27M-Mutant; Thalamus Tumor; Spinal Tumor; IDH1 Mutation; IDH1 R132; IDH1 R132C; IDH1 R132H; IDH1 R132S; IDH1 R132G; IDH1 R132L; Oligodendroglioma Interventions: Drug: Olutasidenib + TMZ Sponsors: Nationwide Children ' s Hospital; Rigel Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Conditions: Recurrent Glioblastoma; Recurrent WHO Grade 4 Glioma Interventions: Biological: Bevacizumab; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Other: Electronic Health Record Review; Radiation: Hypofractionated Radiation Therapy; Procedure: Magnetic Resonance Imaging; Biological: Retifanlimab Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Phase II Trial of Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Conditions: Low-grade Glioma; Pancreatic Cancer Interventions: Drug: Binimetinib 15 MG Sponsors: National Cancer Center, Japan; Ono Pharmaceutical Co. Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Conditions: Low-grade Glioma; Pancreatic Cancer Interventions: Drug: Binimetinib 15 MG Sponsors: National Cancer Center, Japan; Ono Pharmaceutical Co. Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
The Role of B7-H4 in Tumor Vaccine
Conditions: Glioma Interventions: Biological: tumor vaccine Sponsors: Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
